No Data
No Data
Jefferies Maintains ScPharmaceuticals(SCPH.US) With Buy Rating, Cuts Target Price to $13
Express News | ScPharmaceuticals Inc : Jefferies Cuts Target Price to $13 From $16
Earnings Update: ScPharmaceuticals Inc. (NASDAQ:SCPH) Just Reported And Analysts Are Trimming Their Forecasts
Maxim Group Maintains ScPharmaceuticals(SCPH.US) With Buy Rating, Maintains Target Price $20
Positive Outlook for ScPharmaceuticals: Strategic Growth and Regulatory Milestones Drive Buy Rating
ScPharmaceuticals Third Quarter 2024 Earnings: Misses Expectations
No Data